SCHEMBL201888

SCHEMBL201888

NC(=O)CCC(=O)NI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19753121 0.86 KDM4E (0.36)
Succinamide SCHEMBL28157588 0.74 LMNA (0.50)
Succinamide SCHEMBL36057 0.74
SCHEMBL27643837 0.74 FOLH1 (0.57)
SCHEMBL14967033 0.74
SCHEMBL137189 0.74
SCHEMBL18643386 0.74
SCHEMBL17572233 0.74
SCHEMBL4384899 0.72
Ammonia Solution, Strong SCHEMBL2217876 0.72 FOLH1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028308-A1 METHODS FOR MAKING AND USING ENDOXIFEN ATOSSA THERAPEUTICS INC (US) 2026-01-29 US claimed
CN-111592505-A Synthesis method of iodine-catalyzed 2-substituted benzoselenazole compound 衡阳师范学院 2020-08-28 CN claimed
EP-3681491-A1 METHODS FOR MAKING AND USING ENDOXIFEN Atossa Therapeutics, Inc. (US) 2020-07-22 EP claimed
US-20200207704-A1 METHODS FOR MAKING AND USING ENDOXIFEN ATOSSA THERAPEUTICS, INC. 2020-07-02 US claimed
CN-111328280-A Methods of making and using endoxifen 阿托萨治疗学公司 2020-06-23 CN claimed
WO-2019051416-A1 METHODS FOR MAKING AND USING ENDOXIFEN Atossa Genetics Inc. (US) 2019-03-14 WO claimed
CN-104558038-B Preparation method of substituted 2,3-dihydrobenzo[d][1,3] oxa-phosphole ligand 中国科学院上海有机化学研究所 2017-03-22 CN claimed
CN-104558038-A Preparation method of substituted 2,3-dihydrobenzo[d][1,3] oxa-phosphole ligand SHANGHAI INST ORGANIC CHEM 2015-04-29 CN claimed
US-8552162-B2 Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives ENANTA PHARMACEUTICALS, INC. (US) 2013-10-08 US claimed
JP-4554081-B2 2010-09-29 JP claimed
US-20030078413-A1 Process for the synthesis of pyrazolopyrimidines EPOCH BIOSCIENCES, INC. 2003-04-24 US claimed
WO-2003022859-A2 PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES EPOCH BIOSCIENCES, INC. (US) 2003-03-20 WO claimed
EP-1162962-A4 ALKYNYL ARYL SULFONES LONZA AG (US) 2002-10-30 EP claimed
JP-2002522443-A 2002-07-23 JP claimed
EP-1162962-A1 ALKYNYL ARYL SULFONES LONZA INC. (US) 2001-12-19 EP claimed
US-20010025035-A1 Water soluble prodrugs of hindered alcohols UNIVERSITY OF KANSAS 2001-09-27 US claimed
EP-1102776-A1 WATER SOLUBLE PRODRUGS OF HINDERED ALCOHOLS OR PHENOLS THE UNIVERSITY OF KANSAS (US) 2001-05-30 EP claimed
US-6232503-B1 MICROBIOCIDES LONZA INC. 2001-05-15 US claimed
WO-2000056305-A1 ALKYNYL ARYL SULFONES LONZA INC. (US) 2000-09-28 WO claimed
WO-2000008033-A1 WATER SOLUBLE PRODRUGS OF HINDERED ALCOHOLS OR PHENOLS THE UNIVERSITY OF KANSAS (US) 2000-02-17 WO claimed